Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2000
NF-kappa B modulates TNF-alpha production by alveolar macrophages in asymptomatic HIV-seropositive individualsJ M Mathys, S M Melanson, D J Schiffer-Alberts, et al.
Annals of Internal Medicine|June 1, 1995
Early or deferred zidovudine therapy in HIV-infected patients without an AIDS-defining illnessJ P Ioannidis, J C Cappelleri, J Lau, et al.
AIDS (London, England)|October 9, 1998
The effect of protease inhibitors on weight and body composition in HIV-infected patientsM Silva, P R Skolnik, S L Gorbach, et al.
AIDS (London, England)|October 1, 1995
Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replicationJ B Angel, B M Saget, S P Walsh, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 15, 1996
Soluble tumor necrosis factor receptors inhibit phorbol myristate acetate and cytokine-induced HIV-1 expression chronically infected U1 cellsE V Granowitz, B M Saget, J B Angel, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 31, 2012
Acceptance of interferon-gamma release assay by a high-risk urban cohortM R O'Donnell, A Coe, C Bliss, et al.
The Journal of Infectious Diseases|December 1, 1989
Absence of infectious HIV-1 in the urine of seropositive viremic subjectsP R Skolnik, B R Kosloff, L J Bechtel, et al.
Pageof 4